Humana Reports Strong Q1 2025 Financial Results

Humana ( (HUM) ) has provided an announcement.

Humana Inc. reported its financial results for the first quarter of 2025, noting a GAAP earnings per share (EPS) of $10.30 and an adjusted EPS of $11.58. The company affirmed its full-year 2025 adjusted EPS guidance of approximately $16.25, while revising its GAAP EPS guidance to approximately $14.68. Despite an anticipated decline in individual Medicare Advantage membership, Humana remains confident in its pricing strategy and long-term value creation. The company also highlighted progress in its CenterWell and Medicaid businesses, including a new contract in Illinois for a dual eligible special needs plan program.

Spark’s Take on HUM Stock

According to Spark, TipRanks’ AI Analyst, HUM is a Neutral.

Humana’s overall stock score reflects a mix of strengths and challenges. Strong revenue growth and strategic expansions bolster its market position, but declining profitability margins and increasing leverage present financial risks. Technical indicators provide a neutral outlook, while valuation is moderate. The earnings call highlights strategic achievements and operational challenges that balance out these factors. Continued focus on operational efficiency and managing costs will be crucial to improving its financial performance.

To see Spark’s full report on HUM stock, click here.

More about Humana

Humana Inc. is a prominent player in the healthcare industry, primarily offering health insurance services. The company focuses on Medicare Advantage plans, Medicaid, and value-based care, aiming to deliver quality healthcare solutions to a broad range of patients and members.

YTD Price Performance: 4.08%

Average Trading Volume: 1,674,051

Technical Sentiment Signal: Strong Buy

Current Market Cap: $31.77B

For a thorough assessment of HUM stock, go to TipRanks’ Stock Analysis page.